Sundhedsvidenskabelig Forskning ved Aarhus - Institutleder til ...

MEDICINSK-KARDIOLOGISK AFDELING A, ÅRHUS UNIVERSITETSHOSPITAL,
ÅRHUS SYGEHUS
dringer, fødevareproduktion og human sundhed’,
Ugeskrift for læger, vol. 171, nr. 44, s. 3181-4.
Fenger-Grøn, M, Buus, NH & Christensen, KL 2009,
‘Ekkokardiografi af venstre ventrikelmasse ved essentiel
hypertension’, Ugeskrift for læger, vol. 171,
nr. 45, s. 3252-3255.
Færgeman, O, Holme, I, Fayyad, R, Bhatia, S, Grundy,
SM, Kastelein, JJP, LaRosa, JC, Larsen, ML,
Lindahl, C, Olsson, AG, Tikkanen, MJ, Waters, DD,
Pedersen, TR & Steering Committees of IDEAL and
TNT Trials 2009, ‘Plasma triglycerides and cardiovascular
events in the Treating to New Targets and
Incremental Decrease in End-Points through Aggressive
Lipid Lowering trials of statins in patients
with coronary artery disease’, American Journal of
Cardiology, vol. 104, nr. 4, s. 459-63.
Holme, I, Fayyad, R, Færgeman, O, Kastelein, JJP,
Olsson, AG, Tikkanen, MJ, Larsen, ML, Lindahl,
C, Holdaas, H, Pedersen, TR & On behalf of the
Incremental Decrease in End Points Through
Aggressive Lipid Lowering Study Group 2009,
‘Cardiovascular outcomes and their relationships
to lipoprotein components in patients with and
without chronic kidney disease: results from the
IDEAL trial’, Journal of Internal Medicine. E-pub
ahead of print.
Holme, I, Szarek, M, Cater, NB, Færgeman, O, Kastelein,
JJP, Olsson, AG, Tikkanen, MJ, Larsen, ML,
Lindahl, C, Pedersen, TR & Incremental Decrease
in End Points Through Aggressive Lipid Lowering
Study Group 2009, ‘Adherence-adjusted efficacy
with intensive versus standard statin therapy in
patients with acute myocardial infarction in the
IDEAL study’, European Journal of Cardiovascular
Prevention & Rehabilitation, vol. 16, nr. 3, s. 315-20.
Holme, I, Strandberg, TE, Færgeman, O, Kastelein, JJP,
Olsson, AG, Tikkanen, MJ, Larsen, ML, Lindahl,
C, Pedersen, TR & Incremental Decrease in End
Points Through Aggressive Lipid Lowering Study
Group 2009, ‘Congestive heart failure is associated
with lipoprotein components in statin-treated patients
with coronary heart disease Insights from
the Incremental Decrease in End points Through
Aggressive Lipid Lowering Trial (IDEAL)’, Atherosclerosis,
vol. 205, nr. 2, s. 522-7.
Husted, S, Harrington, RA, Cannon, CP, Storey, RF,
Mitchell, P & Emanuelsson, H 2009, ‘Bleeding
risk with AZD6140, a reversible P2Y12 receptor
antagonist, vs. clopidogrel in patients undergoing
coronary artery bypass grafting in the DISPERSE2
trial’, International Journal of Clinical Practice, vol.
63, nr. 4, s. 667-70.
Husted, S 2009, ‘Evidence-based prescribing and adherence
to antiplatelet therapy--how much difference
do they make to patients with atherothrombosis?’,
International Journal of Cardiology, vol. 134, nr. 2,
s. 150-9.
Husted, S & van Giezen, JJJ 2009, ‘Ticagrelor: the first
reversibly binding oral P2Y12 receptor antagonist’,
Cardiovascular therapeutics, vol. 27, nr. 4, s. 259-74.
Husted, S 2009, ‘Unmet needs in oral antiplatelet therapy
with ADP receptor blocking agents’, Fundamental
and Clinical Pharmacology, vol. 23, nr. 1, s. 1-9.
James, S, Akerblom, A, Cannon, CP, Emanuelsson, H,
Husted, S, Katus, H, Skene, A, Steg, PG, Storey,
RF, Harrington, R, Becker, R & Wallentin, L 2009,
‘Comparison of ticagrelor, the first reversible
oral P2Y(12) receptor antagonist, with clopidogrel
in patients with acute coronary syndromes:
Rationale, design, and baseline characteristics
of the PLATelet inhibition and patient Outcomes
(PLATO) trial’, American Heart Journal, vol. 157, nr.
4, s. 599-605.
Knot, J, Widimsky, P, Wijns, W, Stenestrand, U, Kristensen,
SD, Van’ T Hof, A, Weidinger, F, Janzon, M,
Nörgaard, BL, Soerensen, JT, van de Wetering, H,
Thygesen, K, Bergsten, P, Digerfeldt, C, Potgieter,
A, Tomer, N & Fajadet, J 2009, ‘How to set up an
effective national primary angioplasty network:
lessons learned from five European countries’,
EuroIntervention, vol. 5, nr. 3, s. 299, 301-309.
Løfgren, B, Wahlgreen, C, Hoffmann, AM, Poulsen, TS
& Krarup, NH 2009, ‘Genoplivning med automatisk
ekstern defibrillator på hospital’, Ugeskrift for
læger, vol. 171, nr. 5, s. 308-10.
Løfgren, B, Grove, E & Krarup, NH 2009, ‘Hvor er den
automatiske eksterne defibrillator? Udvikling og
uddannelse’, Ugeskrift for læger, vol. 171, nr. 49, s.
3598-9.
Løfgren, B, Grove, E & Krarup, NH 2009, ‘International
sign for automated external defibrillator’, Annals of
Emergency Medicine, vol. 54, nr. 6, s. 855-6.
Løfgren, B, Petersen, CB, Mikkelsen, R, Secher, NG,
Eika, B & Grove, E 2009, ‘Studenterstyret undervisning
i hjerte-lunge-redning og genoplivning
med automatisk ekstern defibrillator’, Ugeskrift for
læger, vol. 171, nr. 49, s. 3592-5.
Nielsen, LH, Munk, K, Gøtzsche, O, Christiansen, EH &
Nørgaard, BL 2009, ‘Takotsubo cardiomyopathy.
An important differential diagnosis to acute myo-
Sundhedsvidenskabelig Forskning ved Aarhus Universitet og Århus Universitetshospital 2009 171